Skip to content
Biodatica
Start free

Investigator

Al Hawkins

ZVELT THERAPEUTICS INC. · funded by NIDDK

Companies
2

Resolved onto their grants.

Grants
2

Federal awards on file.

Non-dilutive funding
$1.3M

Summed across those awards.

First award
Jun 1, 2025

Latest Sep 9, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R42

    Novel Adipose Targeted Gene Therapy for Lipodystrophy

    $975k

    Sep 9, 2025NIDDKZVELT THERAPEUTICS INC.NIH RePORTER · 11185787 (opens the source filing in a new tab)

  2. R42

    ND Enabling Studies for CMT-101, a Novel Gene Therapy for Glycogen Storage Disease 1b

    $300k

    Jun 1, 2025NIDDKCOMETA THERAPEUTICS INCNIH RePORTER · 11067362 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources